| Cheryl Keller-knudson, | |
|
310 5th St., Hayti, SD 57241-0327 | |
| (605) 783-3607 | |
| (605) 783-3259 |
| Full Name | Cheryl Keller-knudson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 310 5th St., Hayti, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972059756 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 235 SLP (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cheryl Keller-knudson, Po Box 327, Hayti, SD 57241-0327 Ph: (605) 783-3607 | Cheryl Keller-knudson, 310 5th St., Hayti, SD 57241-0327 Ph: (605) 783-3607 |
News Archive
Helix Medical, LLC, a global manufacturer for the medical device and healthcare industries, will soon begin construction on a new medical manufacturing facility in Costa Rica. Helix Medical signed a leasing agreement in The Coyol Free Trade Zone and Business Park in Alajuela, Costa Rica, just outside of San Jose. The company will invest more than $4M in the new plant that will soon employ more than 100 people.
Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.
Research by the American Academy of Family Physicians demonstrates that vulvar cancer occurs most frequently in women age 65 to 75 years of age. Thirty percent of patients with vulvar cancer are age 70 or older, and the rate increases with age, reaching a peak of 20 per 100,000 women by 75 years of age.
Japanese researchers have found a piece of the "missing link" about how bone marrow stromal cells restore lost neurologic function when transplanted into animals exhibiting central nervous system disorders, according to a study in the March issue of the Journal of Nuclear Medicine.
CTI BioPharma Corp. today announced that it has received a $10 million milestone payment from Teva Pharmaceutical Industries Ltd. (Teva) related to the achievement of sales milestones for TRISENOX (arsenic trioxide).
› Verified 1 days ago
Linda Conrad, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St., Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 | |
Heather Lynne Hansen, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th Street, Hayti, SD 57241 Phone: 605-783-3607 | |
Marci Saathoff, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th Street, Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 | |
Alysha Johnson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5 Street, Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 | |
Rita Wiese, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St, Hayti, SD 57241 Phone: 605-783-3671 | |
Carrie Niles, MA-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St, Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 | |
Lois Marie Lux, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St., Nesc, Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 |